Cingulate (CINGW) Payables (2021 - 2026)
Cingulate's (CINGW) quarterly Payables came in at $7.1 million in Q2 2026, down 15.34% quarter-over-quarter from $8.3 million in Q4 2025.
Analysis
Cingulate (CINGW) Payables (2021 - 2026) Analysis & Trends
Cingulate (CINGW) has reported Payables for 6 consecutive years, with $7.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Payables changed N/A year-over-year to $7.1 million; the trailing twelve-month figure through Jun 2026 stood at $7.1 million (changed N/A YoY), and the FY2025 full-year result was $8.3 million, up 119.4% from the prior year.
- Payables declined to $7.1 million in Q2 2026 per CINGW's latest filing, from $8.3 million in the prior quarter.
- Across five years, Payables topped out at $9.6 million in Q2 2023 and bottomed at $282265.0 in Q2 2022.
- Historically, Payables has averaged $4.5 million across 5 years, with a median of $4.8 million in 2023.
- The sharpest annual moves came in 2023 and 2024: Payables surged 3305.39% in 2023, then plunged 86.82% in 2024.
- Over 5 years, Payables stood at $5.8 million in 2022, then jumped by 42.29% to $8.2 million in 2023, then plunged by 53.69% to $3.8 million in 2024, then surged by 119.4% to $8.3 million in 2025, then decreased by 15.34% to $7.1 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $7.1 million, $8.3 million, and $4.1 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.46 Bn | 623.70 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 440.11 Bn | 433.54 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 365.04 Bn | 357.90 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | 7.03 Bn |
| 6 | Sanofi | 52.47 Bn | 45.09 Bn | 10.79 Bn | 8.31 Bn |
| 7 | Revolution Medicines | 44.26 Bn | 44.26 Bn | - | 88.42 Mn |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 250.40 Mn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | 497.80 Mn |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | 7.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.05 Mn |
| Dec 31, 2025 | 8.33 Mn |
| Sep 30, 2025 | 4.05 Mn |
| Mar 31, 2025 | 4.98 Mn |
| Dec 31, 2024 | 3.80 Mn |
| Sep 30, 2024 | 906,215.00 |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 737,949.00 |
| Dec 31, 2023 | 8.20 Mn |
| Sep 30, 2023 | 4.67 Mn |
| Jun 30, 2023 | 9.61 Mn |
| Mar 31, 2023 | 5.60 Mn |
| Dec 31, 2022 | 5.76 Mn |
| Sep 30, 2022 | 5.39 Mn |
| Jun 30, 2022 | 282,265.00 |
| Mar 31, 2022 | 556,326.00 |
| Dec 31, 2021 | 264,687.00 |